Author

S. Yazawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

H. Tani· 3 shared K. Oishi· 3 shared M. Itamochi· 3 shared N. Inasaki· 3 shared T. Shimada· 3 shared Y. Saga· 3 shared E. Yamazaki· 2 shared E. Igarashi· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

H. Tani

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyJapanese Journal of Infectious DiseasesPeer-reviewedSep 30, 2023

Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, Japan

H. Tani, N. Inasaki, T. Shimada…·K. Oishi

This study examines neutralizing antibody levels and epidemiological data of patients with breakthrough COVID-19 infections in Toyama, Japan, finding that Omicron BA.1 variants show minimal neutralization despite prior vaccination.

DOI 10.7883/yoken.jjid.2023.100

humanexperimental assay

MicrobiologybioRxivPreprintFeb 16, 2023

Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19

S. Yazawa, E. Yamazaki, Y. Saga…·H. Tani

This study evaluates SARS-CoV-2 isolation efficiency from nasal/nasopharyngeal swabs and saliva, finding lower efficiency in saliva due to inhibitory factors like lactoferrin and amylase.

DOI 10.1101/2023.02.16.528881

humanbulk RNA-seq

MicrobiologybioRxivPreprintSep 27, 2022

Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19

E. Igarashi, T. Shimada, S. Yazawa…·H. Tani

This study examines how trypsin-like proteases affect SARS-CoV-2 infectivity in clinical specimens, finding significant increases for the delta variant compared to omicron.

DOI 10.1101/2022.09.27.509803

humanexperimental assay